Ganciclovir

Hazard statements (CLP)

H340, H351, H360

Code

Statements

H340

May cause genetic defects

SECTION 2: Hazards identification

Directive 67/548/EEC: In accordance with local and national regulations, The product is classified and labelled in accordance with Directive 1999/45/EC. REGULATION (EC) No 1272/2008

EU Classification

Directives 67/548/EEC or 1999/45/EC

Signal word

Danger

Health hazards

Carcinogenicity Category 2 Reproductive toxicity Category 1B Mutagenicity Mutagenic Category 1

Physical hazards

not hazardous

Hazard statements

H351 - Suspected of causing cancer H360 - May damage fertility or the unborn child H340 - May cause genetic defects

Precautionary statements

P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P281 - Use personal protective equipment as required P308 + P313 - IF exposed or concerned: Get medical advice/attention European Union

R-phrase(s)

R40 - Limited evidence of a carcinogenic effect R46 - May cause heritable genetic damage R60 - May impair fertility R61 - May cause harm to the unborn child

S-phrase(s)

S45 - In case of accident or if you feel unwell, seek medical advice immediately (show label where possible) S53 - Avoid exposure - obtain special instructions before use S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection.

Potential health effects

Skin May be harmful in contact with skin. Inhalation May be harmful by inhalation. Ingestion May be harmful if swallowed. Specific effects Carcinogenic effects Possible carcinogen. Mutagenic effects Substances which should be regarded as being mutagenic to man R46 - May cause heritable genetic damage Reproductive toxicity May cause adverse reproductive effects - such as birth defect, miscarriages, or infertility Male reproductive toxin Sensitisation Not applicable